85 related articles for article (PubMed ID: 10761452)
21. [Primary gastric lymphomas. Clinico-pathological study and evaluation of prognostic factors in 65 cases treated surgically].
Pozzi B; Hotz AM; Feltri M; Cornaggia M; Campiotti L; Bonato M; Pinotti G; Capella C
Pathologica; 2000 Dec; 92(6):503-15. PubMed ID: 11234301
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of Fas (CD95/APO-1) positivity in patients with primary nodal diffuse large B-cell lymphoma.
Eser B; Sari I; Canoz O; Altuntas F; Cakmak E; Ozturk A; Ozkan M; Er O; Cetin M; Unal A
Am J Hematol; 2006 May; 81(5):307-14. PubMed ID: 16628716
[TBL] [Abstract][Full Text] [Related]
23. The distinction between Burkitt lymphoma and diffuse large B-Cell lymphoma with c-myc rearrangement.
Nakamura N; Nakamine H; Tamaru J; Nakamura S; Yoshino T; Ohshima K; Abe M
Mod Pathol; 2002 Jul; 15(7):771-6. PubMed ID: 12118116
[TBL] [Abstract][Full Text] [Related]
24. Cluster analysis of apoptosis-associated bcl2 family proteins in diffuse large B-cell lymphomas. Relations with the apoptotic index, the proliferation profile and the B-cell differentiation immunophenotypes.
Bai M; Skyrlas A; Agnantis NJ; Kamina S; Kitsoulis P; Kanavaros P
Anticancer Res; 2004; 24(5A):3081-8. PubMed ID: 15517919
[TBL] [Abstract][Full Text] [Related]
25. Assessment of biological prognostic factors provides clinically relevant information in patients with diffuse large B-cell lymphoma--a Nordic Lymphoma Group study.
Jerkeman M; Anderson H; Dictor M; Kvaløy S; Akerman M; Cavallin-Ståhl E;
Ann Hematol; 2004 Jul; 83(7):414-9. PubMed ID: 15085385
[TBL] [Abstract][Full Text] [Related]
26. Significantly different bcl-2 expression profiles in gastric and non-gastric primary extranodal high-grade B-cell lymphomas.
Cogliatti SB; Griesser H; Peng H; Du MQ; Isaacson PG; Zimmermann DR; Maibach RC; Schmid U
J Pathol; 2000 Dec; 192(4):470-8. PubMed ID: 11113864
[TBL] [Abstract][Full Text] [Related]
27. Low expression of p27 protein combined with altered p53 and Rb/p16 expression status is associated with increased expression of cyclin A and cyclin B1 in diffuse large B-cell lymphomas.
Bai M; Vlachonikolis J; Agnantis NJ; Tsanou E; Dimou S; Nicolaides C; Stefanaki S; Pavlidis N; Kanavaros P
Mod Pathol; 2001 Nov; 14(11):1105-13. PubMed ID: 11706071
[TBL] [Abstract][Full Text] [Related]
28. High-grade mature B-cell lymphoma with Burkitt-like morphology: results of a clinicopathological study of 72 Japanese patients.
Nomura Y; Karube K; Suzuki R; Ying G; Takeshita M; Hirose S; Nakamura S; Yoshino T; Kikuchi M; Ohshima K
Cancer Sci; 2008 Feb; 99(2):246-52. PubMed ID: 18271922
[TBL] [Abstract][Full Text] [Related]
29. p53 expression is a strong marker of inferior survival in de novo diffuse large B-cell lymphoma and may have enhanced negative effect with MYC coexpression: a single institutional clinicopathologic study.
Xie Y; Bulbul MA; Ji L; Inouye CM; Groshen SG; Tulpule A; O'Malley DP; Wang E; Siddiqi IN
Am J Clin Pathol; 2014 Apr; 141(4):593-604. PubMed ID: 24619762
[TBL] [Abstract][Full Text] [Related]
30. Angiogenesis in nodal B cell lymphomas: a high throughput study.
Tzankov A; Heiss S; Ebner S; Sterlacci W; Schaefer G; Augustin F; Fiegl M; Dirnhofer S
J Clin Pathol; 2007 May; 60(5):476-82. PubMed ID: 16790692
[TBL] [Abstract][Full Text] [Related]
31. Expression of p53, c-Myc, or Bcl-6 suggests a poor prognosis in primary central nervous system diffuse large B-cell lymphoma among immunocompetent individuals.
Chang CC; Kampalath B; Schultz C; Bunyi-Teopengco E; Logan B; Eshoa C; Dincer AP; Perkins SL
Arch Pathol Lab Med; 2003 Feb; 127(2):208-12. PubMed ID: 12562237
[TBL] [Abstract][Full Text] [Related]
32. Bcl-6 and c-Myc are rarely co-expressed in adult diffuse large B-cell lymphoma.
Wagner SD; Amen F; Trivedi PS; Horncastle D; Elderfield K; Naresh KN
Leuk Lymphoma; 2007 Aug; 48(8):1510-3. PubMed ID: 17701581
[TBL] [Abstract][Full Text] [Related]
33. Comparison of apoptosis and apoptosis-related gene products between extranodal oral B-cell lymphoma and maxillofacial nodal B-cell lymphoma.
Yin H; Okada N; Takagi M
J Oral Pathol Med; 2001 Mar; 30(3):141-7. PubMed ID: 11271628
[TBL] [Abstract][Full Text] [Related]
34. [Clinical Significance of P53, C-MYC and BCL-6 Abnormality in Patients with Diffuse Large B Cell Lymphoma].
Chai CG; Zhang JJ; Li N; Cao L; Zhang SY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):89-93. PubMed ID: 26913400
[TBL] [Abstract][Full Text] [Related]
35. Expression of the bcl-6 and MUM1/IRF4 proteins correlate with overall and disease-specific survival in patients with primary cutaneous large B-cell lymphoma: a tissue microarray study.
Sundram U; Kim Y; Mraz-Gernhard S; Hoppe R; Natkunam Y; Kohler S
J Cutan Pathol; 2005 Mar; 32(3):227-34. PubMed ID: 15701085
[TBL] [Abstract][Full Text] [Related]
36. Expression of Myc target gene mina53 in subtypes of human lymphoma.
Teye K; Arima N; Nakamura Y; Sakamoto K; Sueoka E; Kimura H; Tsuneoka M
Oncol Rep; 2007 Oct; 18(4):841-8. PubMed ID: 17786344
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of proliferative activity of diffuse large cell lymphomas.
Kossakowska AE; Huchcroft S; Boras V; Urbanski SJ
Hematol Pathol; 1991; 5(3):101-7. PubMed ID: 1960133
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of Ki-67 nuclear proliferative antigen, bcl-2 protein, and p53 expression in follicular and diffuse large B-cell lymphoma.
Llanos M; Alvarez-Argüelles H; Alemán R; Oramas J; Diaz-Flores L; Batista N
Med Oncol; 2001; 18(1):15-22. PubMed ID: 11778965
[TBL] [Abstract][Full Text] [Related]
39. Expression of ice, bcl-2, c-myc and p53 in different bone marrow cell populations from patients with diffuse large B-cell lymphoma.
Madrigal-Velázquez M; Avilés A; Neri N; Huerta J; Martínez-Jaramillo G; Mayani H
Leuk Lymphoma; 2006 Apr; 47(4):665-73. PubMed ID: 16690525
[TBL] [Abstract][Full Text] [Related]
40. [IL-6, p53 and proto-oncogene c-myc play different roles as biological markers of plasma cell dyscrasias].
Alvino S; Marcucci M; Canzoniere D; Mosiello A; Del Monte G; Venturo I; Rinaldi M; Gandolfo GM; Lopez M; Greco C
Clin Ter; 1999; 150(3):197-202. PubMed ID: 10528431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
